| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 2,9 M € | +15.9% | 2,5 M € | +15.4% | 2,2 M € | +5.7% | 2,1 M € | +18.9% | 1,7 M € | -1.0% | 1,8 M € | +32.5% | 1,3 M € | +56.1% | 848,0 k € | +4.5% | 811,7 k € | +20.3% | 674,5 k € | +13.4% | 594,9 k € | +30.7% | 455,1 k € | +7.3% | 424,3 k € | -29.2% | 599,7 k € | -1.2% | 607,2 k € | +5.5% | 575,3 k € | -11.0% | 646,5 k € | +4.8% | 617,1 k € | -6.6% | 660,7 k € | -8.0% | 718,3 k € | |
| EBITDA | 2,8 M € | +14.4% | 2,5 M € | +15.1% | 2,1 M € | +5.5% | 2,0 M € | +19.2% | 1,7 M € | -1.0% | 1,7 M € | +32.2% | 1,3 M € | +54.6% | 843,0 k € | +4.4% | 807,5 k € | +20.7% | 668,8 k € | +13.2% | 590,9 k € | +31.1% | 450,7 k € | +10.4% | 408,2 k € | -28.1% | 567,3 k € | -1.0% | 573,0 k € | +4.8% | 546,5 k € | -11.6% | 617,9 k € | +5.2% | 587,5 k € | -7.6% | 635,8 k € | -7.8% | 690,0 k € | |
| Operating profit | 2,7 M € | +16.4% | 2,3 M € | +17.8% | 2,0 M € | +5.3% | 1,9 M € | +22.4% | 1,5 M € | -1.6% | 1,6 M € | +40.3% | 1,1 M € | +74.4% | 638,9 k € | -11.7% | 723,7 k € | +12.1% | 645,3 k € | +22.8% | 525,3 k € | +18.7% | 442,7 k € | +14.4% | 387,0 k € | -27.8% | 535,9 k € | -1.6% | 544,6 k € | +5.7% | 515,1 k € | -12.1% | 586,3 k € | +4.3% | 562,0 k € | -9.3% | 619,7 k € | -7.0% | 666,0 k € | |
| Profit/loss | 2,1 M € | +15.8% | 1,8 M € | +18.6% | 1,5 M € | +7.7% | 1,4 M € | +21.6% | 1,2 M € | -1.7% | 1,2 M € | +46.7% | 808,4 k € | +58.2% | 511,1 k € | -1.8% | 520,7 k € | +15.3% | 451,4 k € | +20.3% | 375,1 k € | +8.6% | 345,5 k € | +11.9% | 308,7 k € | -25.1% | 412,0 k € | +8.9% | 378,2 k € | +5.2% | 359,4 k € | -14.5% | 420,4 k € | +2.4% | 410,6 k € | -7.2% | 442,6 k € | -3.0% | 456,4 k € | |
| Equity | 6,2 M € | +4.0% | 6,0 M € | +4.4% | 5,7 M € | +7.9% | 5,3 M € | +16.7% | 4,5 M € | +24.1% | 3,7 M € | +45.1% | 2,5 M € | -0.1% | 2,5 M € | +21.8% | 2,1 M € | +24.0% | 1,7 M € | +37.1% | 1,2 M € | +34.9% | 901,9 k € | +31.0% | 688,3 k € | -30.2% | 985,7 k € | -10.9% | 1,1 M € | -10.6% | 1,2 M € | -4.7% | 1,3 M € | +1.2% | 1,3 M € | -7.2% | 1,4 M € | +2.8% | 1,3 M € | |
| Total assets | 6,6 M € | +3.2% | 6,4 M € | -0.3% | 6,4 M € | +8.2% | 5,9 M € | +14.0% | 5,2 M € | +19.0% | 4,3 M € | +9.9% | 4,0 M € | +15.1% | 3,4 M € | +14.9% | 3,0 M € | +7.5% | 2,8 M € | +83.6% | 1,5 M € | +30.1% | 1,2 M € | +27.7% | 912,8 k € | -21.2% | 1,2 M € | -3.8% | 1,2 M € | -8.7% | 1,3 M € | -5.5% | 1,4 M € | -1.6% | 1,4 M € | -6.7% | 1,5 M € | +2.3% | 1,5 M € | |
| Cash | 1,3 M € | -40.5% | 2,3 M € | +44.7% | 1,6 M € | -39.3% | 2,6 M € | +25.0% | 2,1 M € | +65.3% | 1,2 M € | -9.3% | 1,4 M € | +87.5% | 730,0 k € | -34.6% | 1,1 M € | -4.1% | 1,2 M € | +321.4% | 276,3 k € | -48.1% | 532,3 k € | +42.7% | 373,1 k € | -40.0% | 621,8 k € | -1.7% | 632,2 k € | -19.0% | 780,4 k € | -0.7% | 786,1 k € | +67.5% | 469,4 k € | +30.4% | 360,0 k € | -57.3% | 842,7 k € | |
| Debts | 334,8 k € | -8.7% | 366,9 k € | -42.0% | 632,9 k € | +12.0% | 565,2 k € | -5.2% | 596,5 k € | -7.6% | 645,5 k € | -53.0% | 1,4 M € | +49.6% | 917,8 k € | -0.6% | 923,3 k € | -17.3% | 1,1 M € | +272.5% | 299,6 k € | +13.8% | 263,2 k € | +18.1% | 222,9 k € | +29.9% | 171,6 k € | +76.4% | 97,3 k € | +19.8% | 81,2 k € | -15.6% | 96,2 k € | -26.8% | 131,3 k € | -1.0% | 132,7 k € | -4.3% | 138,6 k € | |
| Staff | 1,2 | 0,7 | 0,5 | 0,5 | 0,5 | 0,5 | — | — | — | — | — | — | 0,3 | 0,8 | 0,7 | 0,7 | 0,7 | 0,6 | 0,7 | 0,6 | ||||||||||||||||||||
Public limited company · Kortrijk · incorporated on 15/07/1988 · 1,2 ETP
Public limited company profitable and well capitalised. Cash position declining (-40.5%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
DEBA PHARMA is a Public limited company incorporated in 1988. Its main activity is: Manufacture of pharmaceutical preparations. Its registered office is in Kortrijk. It employs on average 1,2 ETP workers (FTE).
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette